E. Schrader

607 total citations
7 papers, 443 citations indexed

About

E. Schrader is a scholar working on Pharmacology, Complementary and alternative medicine and Psychiatry and Mental health. According to data from OpenAlex, E. Schrader has authored 7 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Complementary and alternative medicine and 2 papers in Psychiatry and Mental health. Recurrent topics in E. Schrader's work include Medicinal Plant Extracts Effects (2 papers), Hops Chemistry and Applications (2 papers) and Schizophrenia research and treatment (2 papers). E. Schrader is often cited by papers focused on Medicinal Plant Extracts Effects (2 papers), Hops Chemistry and Applications (2 papers) and Schizophrenia research and treatment (2 papers). E. Schrader collaborates with scholars based in Germany, Switzerland and Canada. E. Schrader's co-authors include Joseph M. Rey, Allen Morris‐Yates, Beat H. Meier, A. Brattström, Uwe Koetter, Dave K. Berger, W. Schaffner, Hans‐Heinrich Henneicke‐von Zepelin and P W Wüstenberg and has published in prestigious journals such as Phytotherapy Research, Journal of Adolescence and Planta Medica.

In The Last Decade

E. Schrader

6 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Schrader Germany 6 194 157 93 54 54 7 443
Marcus Mannel Germany 11 200 1.0× 202 1.3× 37 0.4× 92 1.7× 29 0.5× 16 544
Michael Nathan Israel 9 103 0.5× 118 0.8× 111 1.2× 29 0.5× 55 1.0× 15 576
Qing S. Li United States 16 86 0.4× 242 1.5× 49 0.5× 73 1.4× 36 0.7× 28 717
W.-D. Hübner Germany 7 280 1.4× 182 1.2× 27 0.3× 77 1.4× 15 0.3× 9 394
Janet Konefal United States 12 52 0.3× 197 1.3× 36 0.4× 62 1.1× 31 0.6× 36 517
Paul Crichton United Kingdom 7 56 0.3× 117 0.7× 69 0.7× 20 0.4× 25 0.5× 20 442
Ali Pourmotabbed Iran 16 90 0.5× 47 0.3× 57 0.6× 102 1.9× 130 2.4× 53 965
S. Taavoni Iran 16 53 0.3× 154 1.0× 35 0.4× 51 0.9× 194 3.6× 78 700
Kanwal Preet Kochhar India 9 61 0.3× 85 0.5× 62 0.7× 45 0.8× 198 3.7× 35 538
Britt Sanford United States 4 247 1.3× 50 0.3× 20 0.2× 56 1.0× 12 0.2× 6 450

Countries citing papers authored by E. Schrader

Since Specialization
Citations

This map shows the geographic impact of E. Schrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schrader more than expected).

Fields of papers citing papers by E. Schrader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schrader. The network helps show where E. Schrader may publish in the future.

Co-authorship network of co-authors of E. Schrader

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schrader. A scholar is included among the top collaborators of E. Schrader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schrader. E. Schrader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Koetter, Uwe, E. Schrader, & A. Brattström. (2006). Effects of hops on clinical efficacy of a valerian-hops-extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Planta Medica. 72(11). 1 indexed citations
3.
Berger, Dave K., W. Schaffner, E. Schrader, Beat H. Meier, & A. Brattström. (2000). Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Archives of Gynecology and Obstetrics. 264(3). 150–153. 67 indexed citations
4.
Schrader, E.. (2000). Equivalence of St Johnʼs wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mildmoderate depression. International Clinical Psychopharmacology. 15(2). 61–68. 162 indexed citations
5.
Schrader, E., et al.. (2000). Benefit of a fixed drug combination containing St John's Wort and Black Cohosh for climacteric patients – results of a randomised clinical trial. Focus on Alternative and Complementary Therapies. 5(1). 85–86. 6 indexed citations
6.
Schrader, E., et al.. (1998). Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Human Psychopharmacology Clinical and Experimental. 13(3). 163–169. 53 indexed citations
7.
Rey, Joseph M., E. Schrader, & Allen Morris‐Yates. (1992). Parent‐child agreement on children's behaviours reported by the child behaviour checklist (CBCL). Journal of Adolescence. 15(3). 219–230. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026